載入...
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
Down syndrome (DS) is one of the leading causes of intellectual disability, and patients with DS face various health issues, including learning and memory deficits, congenital heart disease, Alzheimer’s disease (AD), leukemia, and cancer, leading to huge medical and social costs. Remarkable advances...
Na minha lista:
| 發表在: | Front Behav Neurosci |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4891327/ https://ncbi.nlm.nih.gov/pubmed/27375444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnbeh.2016.00104 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|